Description:
A drug used to treat adults with breast cancer that cannot be removed by surgery or has spread to other parts of the body, has been treated with other therapies, and is hormone receptor positive (HR+) and HER2-negative. It is also being studied in the treatment of other types of cancer. Datroway contains a monoclonal antibody called datopotamab that binds to a protein called TROP2, which is found on some cancer cells. It also contains an anticancer drug called deruxtecan, which may help kill cancer cells. Datroway is a type of antibody-drug conjugate. Also called datopotamab deruxtecan.
